23 results on '"Samantha B Kasloff"'
Search Results
2. Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic.
- Author
-
Gary Mallach, Samantha B Kasloff, Tom Kovesi, Anand Kumar, Ryan Kulka, Jay Krishnan, Benoit Robert, Michaeline McGuinty, Sophia den Otter-Moore, Bashour Yazji, and Todd Cutts
- Subjects
Medicine ,Science - Abstract
BackgroundFew studies have quantified aerosol concentrations of SARS-CoV-2 in hospitals and long-term care homes, and fewer still have examined samples for viability. This information is needed to clarify transmission risks beyond close contact.MethodsWe deployed particulate air samplers in rooms with COVID-19 positive patients in hospital ward and ICU rooms, rooms in long-term care homes experiencing outbreaks, and a correctional facility experiencing an outbreak. Samplers were placed between 2 and 3 meters from the patient. Aerosol (small liquid particles suspended in air) samples were collected onto gelatin filters by Ultrasonic Personal Air Samplers (UPAS) fitted with ResultsIn total, 138 samples were collected from 99 rooms. RNA samples were positive in 9.1% (6/66) of samples obtained with the UPAS 2.5μm samplers, 13.5% (7/52) with the UPAS 10μm samplers, and 10.0% (2/20) samples obtained with the Coriolis samplers. Culturable virus was not recovered in any samples. Viral RNA was detected in 15.1% of the rooms sampled. There was no significant difference in viral RNA recovery between the different room locations or samplers. Method development experiments indicated minimal loss of SARS-CoV-2 viability via the personal air sampler operation.
- Published
- 2021
- Full Text
- View/download PDF
3. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods.
- Author
-
Anand Kumar, Samantha B Kasloff, Anders Leung, Todd Cutts, James E Strong, Kevin Hills, Frank X Gu, Paul Chen, Gloria Vazquez-Grande, Barret Rush, Sylvain Lother, Kimberly Malo, Ryan Zarychanski, and Jay Krishnan
- Subjects
Medicine ,Science - Abstract
The response to the COVID-19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted, with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 7 different decontamination methods: autoclave treatment, ethylene oxide gassing (ETO), low temperature hydrogen peroxide gas plasma (LT-HPGP) treatment, vaporous hydrogen peroxide (VHP) exposure, peracetic acid dry fogging (PAF), ultraviolet C irradiation (UVCI) and moist heat (MH) treatment to decontaminate a variety of different N95 masks following experimental contamination with SARS-CoV-2 or vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. All methods except for UVCI were effective in total elimination of viable virus from treated masks. We found that all respirator masks tolerated at least one cycle of all treatment modalities without structural or functional deterioration as assessed by fit testing; filtration efficiency testing results were mostly similar except that a single cycle of LT-HPGP was associated with failures in 3 of 6 masks assessed. VHP, PAF, UVCI, and MH were associated with preserved mask integrity to a minimum of 10 cycles by both fit and filtration testing. A similar result was shown with ethylene oxide gassing to the maximum 3 cycles tested. Pleated, layered non-woven fabric N95 masks retained integrity in fit testing for at least 10 cycles of autoclaving but the molded N95 masks failed after 1 cycle; filtration testing however was intact to 5 cycles for all masks. The successful application of autoclaving for layered, pleated masks may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings. Given the ability to modify widely available heating cabinets on hospital wards in well-resourced settings, the application of moist heat may allow local processing of N95 masks.
- Published
- 2020
- Full Text
- View/download PDF
4. Standard hospital blanket warming cabinets can be utilized for complete moist heat SARS-CoV2 inactivation of contaminated N95 masks for re-use
- Author
-
Anand Kumar, Samantha B. Kasloff, Todd Cutts, Anders Leung, Naresh Sharma, Gloria Vazquez-Grande, Tracy Drew, Denis Laframboise, Olivero Orofino, Joe Tanelli, and Jay Krishnan
- Subjects
Medicine ,Science - Abstract
Abstract Shortages of personal protective equipment for use during the SARS-CoV-2 pandemic continue to be an issue among health-care workers globally. Extended and repeated use of N95 filtering facepiece respirators without adequate decontamination is of particular concern. Although several methods to decontaminate and re-use these masks have been proposed, logistic or practical issues limit adoption of these techniques. In this study, we propose and validate the use of the application of moist heat (70 °C with humidity augmented by an open pan of water) applied by commonly available hospital (blanket) warming cabinets to decontaminate N95 masks. This report shows that a variety of N95 masks can be repeatedly decontaminated of SARS-CoV-2 over 6 h moist heat exposure without compromise of their filtering function as assessed by standard fit and sodium chloride aerosol filtration efficiency testing. This approached can easily adapted to provide point-of-care N95 mask decontamination allowing for increased practical utility of mask recycling in the health care setting.
- Published
- 2021
- Full Text
- View/download PDF
5. Stability of SARS-CoV-2 on critical personal protective equipment
- Author
-
Samantha B. Kasloff, Anders Leung, James E. Strong, Duane Funk, and Todd Cutts
- Subjects
Medicine ,Science - Abstract
Abstract The spread of COVID-19 in healthcare settings is concerning, with healthcare workers representing a disproportionately high percentage of confirmed cases. Although SARS-CoV-2 virus has been found to persist on surfaces for a number of days, the extent and duration of fomites as a mode of transmission, particularly in healthcare settings, has not been fully characterized. To shed light on this critical matter, the present study provides the first comprehensive assessment of SARS-CoV-2 stability on experimentally contaminated personal protective equipment (PPE) widely used by healthcare workers and the general public. Persistence of viable virus was monitored over 21 days on eight different materials, including nitrile medical examination gloves, reinforced chemical resistant gloves, N-95 and N-100 particulate respirator masks, Tyvek, plastic, cotton, and stainless steel. Unlike previous reports, viable SARS-CoV-2 in the presence of a soil load persisted for up to 21 days on experimentally inoculated PPE, including materials from filtering facepiece respirators (N-95 and N-100 masks) and a plastic visor. Conversely, when applied to 100% cotton fabric, the virus underwent rapid degradation and became undetectable by TCID50 assay within 24 h. These findings underline the importance of appropriate handling of contaminated PPE during and following use in high-risk settings and provide interesting insight into the potential utility of cotton in limiting COVID-19 transmission.
- Published
- 2021
- Full Text
- View/download PDF
6. Mechanical Wiping Increases the Efficacy of Liquid Disinfectants on SARS-CoV-2
- Author
-
Angela Sloan, Samantha B. Kasloff, and Todd Cutts
- Subjects
SARS-CoV-2 ,biocide ,disinfection ,fomites ,QCT-2 ,wiping ,Microbiology ,QR1-502 - Abstract
High-touch environmental surfaces are acknowledged as potential sources of pathogen transmission, particularly in health care settings where infectious agents may be readily abundant. Methods of disinfecting these surfaces often include direct application of a chemical disinfectant or simply wiping the surface with a disinfectant pre-soaked wipe (DPW). In this study, we examine the ability of four disinfectants, ethanol (EtOH), sodium hypochlorite (NaOCl), chlorine dioxide (ClO2), and potassium monopersulfate (KMPS), to inactivate SARS-CoV-2 on a hard, non-porous surface, assessing the effects of concentration and contact time. The efficacy of DPWs to decontaminate carriers spiked with SARS-CoV-2, as well as the transferability of the virus from used DPWs to clean surfaces, is also assessed. Stainless steel carriers inoculated with approximately 6 logs of SARS-CoV-2 prepared in a soil load were disinfected within 5 min through exposure to 66.5% EtOH, 0.5% NaOCl, and 1% KMPS. The addition of mechanical wiping using DPWs impregnated with these biocides rendered the virus inactive almost immediately, with no viral transfer from the used DPW to adjacent surfaces. Carriers treated with 100 ppm of ClO2 showed a significant amount of viable virus remaining after 10 min of biocide exposure, while the virus was only completely inactivated after 10 min of treatment with 500 ppm of ClO2. Wiping SARS-CoV-2-spiked carriers with DPWs containing either concentration of ClO2 for 5 s left significant amounts of viable virus on the carriers. Furthermore, higher titers of infectious virus retained on the ClO2-infused DPWs were transferred to uninoculated carriers immediately after wiping. Overall, 66.5% EtOH, 0.5% NaOCl, and 1% KMPS appear to be highly effective biocidal agents against SARS-CoV-2, while ClO2 formulations are much less efficacious.
- Published
- 2022
- Full Text
- View/download PDF
7. Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes
- Author
-
Todd A. Cutts, Catherine Robertson, Steven S. Theriault, Raymond W. Nims, Samantha B. Kasloff, Joseph R. Rubino, and M. Khalid Ijaz
- Subjects
ASTM E2967-15 ,Disinfectant pre-soaked wipes ,Ebola virus—Makona strain ,inactivation ,removal ,transfer ,Public aspects of medicine ,RA1-1270 - Abstract
Disinfectant pre-soaked wipes (DPW) containing activated hydrogen peroxide (AHP) or quaternary ammonium compounds (QAC) were tested using ASTM E2967-15 to determine removal, transfer, and inactivation of Ebola virus Makona variant (EBOV/Mak) and vesicular stomatitis virus (VSV) from contaminated stainless steel prototypic environmental surfaces. The infectious virus-contaminated carriers were subjected to wiping in the Wiperator per the standard. Following the use of negative control (J-Cloth)-, AHP-, or QAC-based wipes, recovery of residual infectious virus was assayed. In the case of the J-Cloth wipes (negative control), although removal of virus from inoculated carriers was extensive i.e., ~99% (1.9–3.5 log10) transfer of virus by these wipes to a secondary surface amounted to ≤ 2% (~3.8 log10) of the initial virus load. In the case of each DPW, >6 log10 removal/inactivation of virus was observed, with limited (EBOV/Mak) or no (VSV) virus transfer observed. The efficacy of wipes for decontaminating high-touch environmental surfaces spiked with EBOV/Mak or VSV is discussed. In summary, removal of EBOV/Mak and VSV using wipes was extensive in this study. In the absence of a sufficient concentration and contact time of an appropriate microbicidal active in DPW (such as the AHP- and QAC-based DPW tested), transfer of a low, albeit significant (from an infectious unit/infectious dose perspective), quantity of infectious virus from the inoculated surface to a secondary surface was observed. In the case of Ebola virus, it is essential that a DPW with an appropriate microbicidal active, following the appropriate contact time, be used to prevent unintended transfer of infectious virus to a clean secondary surface (as observed in negative control /J-Cloth). Otherwise, there exists the possibility of dissemination of Ebola virus and the associated risk of transmission of Ebola virus disease.
- Published
- 2020
- Full Text
- View/download PDF
8. Efficacy of microbicides for inactivation of Ebola–Makona virus on a non-porous surface: a targeted hygiene intervention for reducing virus spread
- Author
-
Samantha B Kasloff, Todd Cutts, Catherine Robertson, M. Khalid Ijaz, Steven Theriault, Joseph R. Rubino, and Raymond W. Nims
- Subjects
0301 basic medicine ,Sodium Hypochlorite ,Surface Properties ,media_common.quotation_subject ,Disinfectant ,030106 microbiology ,lcsh:Medicine ,Diseases ,In Vitro Techniques ,Xylenes ,medicine.disease_cause ,Microbiology ,Virus ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Anti-Infective Agents ,Cytopathogenic Effect, Viral ,Hygiene ,Chlorocebus aethiops ,Environmental Microbiology ,medicine ,Animals ,Humans ,Chloroxylenol ,lcsh:Science ,Vero Cells ,media_common ,Cytopathic effect ,Multidisciplinary ,Ebola virus ,Ethanol ,Chemistry ,lcsh:R ,Health care ,Hemorrhagic Fever, Ebola ,Ebolavirus ,Microbicides for sexually transmitted diseases ,030104 developmental biology ,Sodium hypochlorite ,Virus Inactivation ,lcsh:Q ,Porosity ,Disinfectants ,medicine.drug - Abstract
Microbicides play critical roles in infection prevention and control of Ebola virus by decontaminating high-touch environmental surfaces (HITES), interrupting the virus-HITES-hands nexus. We evaluated the efficacy of formulations containing different microbicidal actives for inactivating Ebola virus–Makona strain (EBOV/Mak) on stainless-steel carriers per ASTM E2197-11. Formulations of sodium hypochlorite (NaOCl) (0.05–1%), ethanol (70%), chloroxylenol (PCMX) (0.12–0.48% by weight) in hard water, and a ready-to-use disinfectant spray with 58% ethanol (EDS), were tested at contact times of 0, or 0.5 to 10 min at ambient temperature. EBOV/Mak was inactivated (> 6 log10) by 70% ethanol after contact times ≥ 2.5 min, by 0.5% and 1% NaOCl or EDS (> 4 log10) at contact times ≥ 5 min, and by 0.12–0.48% PCMX (> 4.2 log10) at contact times ≥ 5 min. Residual infectious virus in neutralized samples was assessed by passage on cells and evaluation for viral cytopathic effect. No infectious virus was detected in cells inoculated with EBOV/Mak exposed to NaOCl (0.5% or 1%), PCMX (0.12% to 0.48%), or EDS for ≥ 5 min. These results demonstrate ≥ 6 log10 inactivation of EBOV/Mak dried on prototypic surfaces by EDS or formulations of NaOCl (≥ 0.5%), PCMX (≥ 0.12%), or 70% ethanol at contact times ≥ 5 min.
- Published
- 2020
9. Standard hospital blanket warming cabinets can be utilized for complete moist heat SARS-CoV2 inactivation of contaminated N95 masks for re-use
- Author
-
Jay Krishnan, Naresh Chand Sharma, Todd Cutts, Denis Laframboise, Tracy Drew, Anders Leung, Samantha B Kasloff, Joe Tanelli, Gloria Vazquez-Grande, Olivero Orofino, and Anand Kumar
- Subjects
business.product_category ,Time Factors ,N95 Respirators ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Science ,Point-of-Care Systems ,Economic shortage ,Diseases ,Blanket ,Article ,Equipment Reuse ,Humans ,Respirator ,Personal protective equipment ,Decontamination ,Biophysical methods ,Multidisciplinary ,Waste management ,SARS-CoV-2 ,fungi ,Biological techniques ,Humidity ,Human decontamination ,Contamination ,Hospitals ,Viral infection ,Environmental science ,Medicine ,Infectious diseases ,Virus Inactivation ,business ,Microbiology techniques - Abstract
Shortages of personal protective equipment for use during the SARS-CoV-2 pandemic continue to be an issue among health-care workers globally. Extended and repeated use of N95 filtering facepiece respirators without adequate decontamination is of particular concern. Although several methods to decontaminate and re-use these masks have been proposed, logistic or practical issues limit adoption of these techniques. In this study, we propose and validate the use of the application of moist heat (70 °C with humidity augmented by an open pan of water) applied by commonly available hospital (blanket) warming cabinets to decontaminate N95 masks. This report shows that a variety of N95 masks can be repeatedly decontaminated of SARS-CoV-2 over 6 h moist heat exposure without compromise of their filtering function as assessed by standard fit and sodium chloride aerosol filtration efficiency testing. This approached can easily adapted to provide point-of-care N95 mask decontamination allowing for increased practical utility of mask recycling in the health care setting.
- Published
- 2021
10. Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic
- Author
-
Michaeline McGuinty, Sophia den Otter-Moore, Todd Cutts, Ryan Kulka, Samantha B Kasloff, Gary Mallach, Benoit Robert, Tom Kovesi, Anand Kumar, Jay Krishnan, and Bashour Yazji
- Subjects
RNA viruses ,Veterinary medicine ,Viral Diseases ,Pulmonology ,Coronaviruses ,Air Microbiology ,Medical Conditions ,Animal Products ,Chlorocebus aethiops ,Materials ,Pathology and laboratory medicine ,Multidisciplinary ,Agriculture ,Medical microbiology ,Method development ,Hospitals ,Infectious Diseases ,Vesicular Stomatitis Virus ,Physical Sciences ,Viruses ,Medicine ,RNA, Viral ,SARS CoV 2 ,Pathogens ,Protein target ,Research Article ,Coronavirus disease 2019 (COVID-19) ,SARS coronavirus ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Science ,Materials Science ,complex mixtures ,Microbiology ,Rhabdoviruses ,Respiratory Disorders ,Animals ,Humans ,Viral rna ,Hospital ward ,Close contact ,Vero Cells ,Aerosols ,Medicine and health sciences ,Biology and life sciences ,SARS-CoV-2 ,Significant difference ,fungi ,Organisms ,Viral pathogens ,COVID-19 ,Covid 19 ,Long-Term Care ,Aerosol ,Microbial pathogens ,Health Care ,Health Care Facilities ,Mixtures ,Respiratory Infections ,Environmental science ,Gelatin - Abstract
BackgroundFew studies have quantified aerosol concentrations of SARS-CoV-2 in hospitals and long-term care homes, and fewer still have examined samples for viability. This information is needed to clarify transmission risks beyond close contact.MethodsWe deployed particulate air samplers in rooms with COVID-19 positive patients in hospital ward and ICU rooms, rooms in long-term care homes experiencing outbreaks, and a correctional facility experiencing an outbreak. Samplers were placed between 2 and 3 meters from the patient. Aerosol (small liquid particles suspended in air) samples were collected onto gelatin filters by Ultrasonic Personal Air Samplers (UPAS) fitted with 3), and with a Coriolis Biosampler over 10 minutes (total 1.5m3). Samples were assayed for viable SARS-CoV-2 virus and for the viral genome by multiplex PCR using the E and N protein target sequences. We validated the sampling methods by inoculating gelatin filters with viable vesicular stomatitis virus (VSV), and with three concentrations of viable SARS-CoV-2, operating personal samplers for 16hrs, and quantifying viable virus recovery by TCID50 assay.ResultsIn total, 138 samples were collected from 99 rooms. RNA samples were positive in 9.1% (6/66) of samples obtained with the UPAS 2.5µm samplers, 13.5% (7/52) with the UPAS 10µm samplers, and 10.0% (2/20) samples obtained with the Coriolis samplers. Culturable virus was not recovered in any samples. Viral RNA was detected in 10.9% of the rooms sampled. There was no significant difference in viral RNA recovery between the different room locations or samplers. Method development experiments indicated minimal loss of SARS-CoV-2 viability via the personal air sampler operation.Key FindingsAlthough a subset of aerosol samples exhibited detectable SARS-CoV-2 RNA at low titres, the presence of viable SARS-CoV-2 virus in aerosols appears to be infrequent at >2m distance.
- Published
- 2021
11. Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus
- Author
-
Todd A. Cutts, Samantha B. Kasloff, Jay Krishnan, Raymond W. Nims, Steven S. Theriault, Joseph R. Rubino, and M. Khalid Ijaz
- Subjects
Serotype ,viral removal/inactivation ,Disinfectant ,viruses ,medicine.disease_cause ,Virus ,chemistry.chemical_compound ,medicine ,Animals ,ASTM E2967-15 ,Hydrogen peroxide ,wiperator ,Original Research ,Ebola virus ,biology ,disinfectant pre-impregnated wipes ,Public Health, Environmental and Occupational Health ,technology, industry, and agriculture ,Hemorrhagic Fever, Ebola ,biology.organism_classification ,Ebolavirus ,Stainless Steel ,Virology ,Ebola virus Makona variant ,chemistry ,Vesicular stomatitis virus ,Sodium hypochlorite ,Vero cell ,Public Health ,Public aspects of medicine ,RA1-1270 ,vesicular stomatitis virus ,Vesicular Stomatitis ,Disinfectants - Abstract
The authors evaluated four disinfectant pre-impregnated wipes (DPW) for efficacy against Ebola virus Makona variant (EBOV) and vesicular stomatitis virus (VSV), Indiana serotype. Steel carriers were inoculated with the infectious virus and then were wiped with DPW in the Wiperator instrument per ASTM E2967-15. Following the use of J-Cloth impregnated with medium (negative control wipes) or the use of activated hydrogen peroxide (AHP)-, ethanol-, sodium hypochlorite (NaOCl)-, or single or dual quaternary ammonium compound (QAC)-based DPW, virus recovery from the carriers was assayed by titration assay and by two passages on Vero E6 cells in 6-well plates. The Wiperator also enabled the measurement of potential transfer of the virus from the inoculated carrier to a secondary carrier by the DPW or control wipes. The J-Cloth wipes wetted with medium alone (no microbicidal active) removed 1.9–3.5 log10 of virus from inoculated carriers but transferred ~4 log10 of the wiped virus to secondary carriers. DPW containing AHP, ethanol, NaOCl, or single or dual QAC as active microbicidal ingredients removed/inactivated ~6 log10 of the virus, with minimal EBOV or no VSV virus transfer to a secondary surface observed. In Ebola virus outbreaks, a DPW with demonstrated virucidal efficacy, used as directed, may help to mitigate the unintended spread of the infectious virus while performing surface cleaning.
- Published
- 2021
12. Efficacy Testing of Personal Protective Filters on Biosafety Level 4 Positive Pressure Suits
- Author
-
Samantha B Kasloff, Todd Cutts, Anders Leung, Jay Krishnan, Gabriel Lightly, Laura Landry, and Greg Fey
- Subjects
Biosafety level 4 ,0303 health sciences ,030306 microbiology ,business.industry ,Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health ,Positive pressure ,Original Articles ,030501 epidemiology ,Management, Monitoring, Policy and Law ,medicine.disease ,Biocontainment ,Positive pressure breathing ,03 medical and health sciences ,Medicine ,Medical emergency ,0305 other medical science ,business ,Personal protective equipment ,Biotechnology - Abstract
Introduction: Positive pressure breathing air-fed protective suits from three vendors are commonly used in biosafety level 4 (BSL-4) laboratories: they are Dover Chemturion suits (ILC Dover, DE), Delta suits (Honeywell Safety, NC), and HVO suits (HVO-ISSI-Deutschland GmbH, Germany). To address the potential risk of infectious agents being introduced through the supplied breathing air stream, some suit manufacturers incorporate protective filters on the suits themselves. However, these integrated filters are not amenable to in situ testing for efficacy verification. We have been using external filters from Matheson USA on the positive pressure suits since our BSL-4 laboratories were commissioned two decades ago. As part of our BSL-4 protective suit management program, we test these filters before them being put into use, and annually thereafter. In the past few years, we have observed these filters failing at a higher rate, as high as two out of three of the new filters tested at one point. Objective: The purpose of this study was to procure personal protective filters from other sources and validate their efficacy long-term. Methods: Filters from Respirex, HVO, and Honeywell were validated for filter integrity and filter loading. Results: Respirex filters performed well during the initial testing and periodic testing thereafter. Regular testing of the Respirex filters has now been ongoing for 30 months with continued successful performance. Conclusion: Filters from Respirex are a suitable option to protect personnel wearing positive pressure suits in BSL-4 laboratories.
- Published
- 2021
13. Decontamination of N95 Respirators using Moist Heat Delivered by Hospital Blanket Warming Cabinets: A Widely Available Method for N95 Re-Processing
- Author
-
Jay Krishnan, Gloria Vazquez-Grande, Samantha B Kasloff, Joe Tanelli, Tracy Drew, Denis Laframboise, Anand Kumar, Anders Leung, Olivero Orofino, Naresh Chand Sharma, and Todd Cutts
- Subjects
business.product_category ,Waste management ,Environmental science ,Human decontamination ,Blanket ,Respirator ,business - Abstract
Shortages of personal protective equipment for use during the SARS-CoV-2 pandemic continue to be an issue among health-care workers globally. Extended and repeated use of N95 filtering facepiece respirators without adequate decontamination is of particular concern. Although several methods to decontaminate and re-use these masks have been proposed, logistic or practical issues limit adoption of these techniques. In this study, we propose and validate the use of the application of moist heat (70oC with humidity augmented by an open pan of water) applied by commonly available hospital (blanket) warming cabinets to decontaminate N95 masks. This report shows that a variety of N95 masks can be repeatedly decontaminated of SARS-CoV-2 over 6 hours moist heat exposure without compromise of their filtering function as assessed by standard fit and sodium chloride aerosol filtration efficiency testing. This approached can easily adapted to provide point-of-care N95 mask decontamination allowing for increased practical utility of mask recycling in the health care setting.
- Published
- 2021
14. Stability of SARS-CoV-2 on critical personal protective equipment
- Author
-
Todd Cutts, Anders Leung, Duane J. Funk, Samantha B Kasloff, and James E. Strong
- Subjects
0301 basic medicine ,2019-20 coronavirus outbreak ,business.product_category ,Coronavirus disease 2019 (COVID-19) ,Surface Properties ,Science ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,030106 microbiology ,Policy and public health in microbiology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Viral genetics ,Virology ,Environmental health ,Medicine ,030212 general & internal medicine ,Respirator ,Personal Protective Equipment ,Personal protective equipment ,Multidisciplinary ,SARS-CoV-2 ,business.industry ,Limiting ,Healthcare settings ,RNA, Viral ,business ,Porosity - Abstract
The spread of COVID-19 in healthcare settings is concerning, with healthcare workers representing a disproportionately high percentage of confirmed cases. Although SARS-CoV-2 virus has been found to persist on surfaces for a number of days, the extent and duration of fomites as a mode of transmission, particularly in healthcare settings, has not been fully characterized. To shed light on this critical matter, the present study provides the first comprehensive assessment of SARS-CoV-2 stability on experimentally contaminated personal protective equipment (PPE) widely used by healthcare workers and the general public. Persistence of viable virus was monitored over 21 days on eight different materials, including nitrile medical examination gloves, reinforced chemical resistant gloves, N-95 and N-100 particulate respirator masks, Tyvek, plastic, cotton, and stainless steel. Unlike previous reports, viable SARS-CoV-2 in the presence of a soil load persisted for up to 21 days on experimentally inoculated PPE, including materials from filtering facepiece respirators (N-95 and N-100 masks) and a plastic visor. Conversely, when applied to 100% cotton fabric, the virus underwent rapid degradation and became undetectable by TCID50 assay within 24 h. These findings underline the importance of appropriate handling of contaminated PPE during and following use in high-risk settings and provide interesting insight into the potential utility of cotton in limiting COVID-19 transmission.
- Published
- 2021
15. Patient-reported outcome measures in ophthalmology: too difficult to read?
- Author
-
Tina Felfeli, Tony Mazzulli, Samantha B Kasloff, Jay Krishnan, Sherif R El-Defrawy, and Todd A Cutts
- Subjects
retina ,medicine.medical_specialty ,Population ,degeneration ,Prom ,03 medical and health sciences ,0302 clinical medicine ,RA0421 ,Ophthalmology ,medicine ,macula ,030212 general & internal medicine ,education ,Original Research ,education.field_of_study ,business.industry ,Public health ,public health ,RE1-994 ,Readability ,Test (assessment) ,Clinical trial ,glaucoma ,030221 ophthalmology & optometry ,Patient-reported outcome ,RE ,Metric (unit) ,business - Abstract
ObjectivePatient-reported outcome measures (PROMs) are commonly used in clinical trials and research. Yet, in order to be effective, a PROM needs to be understandable to respondents. The aim of this cross-sectional analysis was to assess reading level of PROMs validated for use in common eye conditions.Methods and analysisReadability measures determine the level of education a person is expected to have attained to be able to read a passage of text; this was calculated using the Flesch-Kincaid Grade Level, FORCAST and Gunning-Fog tests within readability calculations software package Oleander Readability Studio 2012.1. Forty PROMs, previously validated for use in at least one of age-related macular degeneration, glaucoma and/or diabetic retinopathy, were identified for inclusion via a systematic literature search. The American Medical Association (AMA) and National Institutes of Health (NIH) recommend patient materials should not exceed a sixth-grade reading level. Number of PROMs exceeding this level was calculated.ResultsMedian (IQR) readability scores were 7.9 (5.4–10.5), 9.9 (8.9–10.7) and 8.4 (6.9–11.1) for Flesch-Kincaid Grade Level, FORCAST and Gunning-Fog test, respectively. Depending on metric used, this meant 61% (95% CI 45% to 76%), 100% (95% CI 91% to 100%) and 80% (95% CI 65% to 91%) exceeded the recommended threshold.ConclusionMost PROMs commonly used in ophthalmology require a higher reading level than that recommended by the AMA and NIH and likely contain questions that are too difficult for many patients to read. Greater care is needed in designing PROMs appropriate for the literacy level of a population.
- Published
- 2021
16. Decontamination of Common Healthcare Facility Surfaces Contaminated with SARS-CoV-2 using Peracetic Acid Dry Fogging
- Author
-
Jay Krishnan, David Safronetz, Todd Cutts, and Samantha B Kasloff
- Subjects
Microbiology (medical) ,Fogging ,Surface Properties ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,030501 epidemiology ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Peracetic acid ,Intensive care ,Equipment Reuse ,Medicine ,Peracetic Acid ,Decontamination ,Infectious virus ,0303 health sciences ,SARS-CoV-2 ,030306 microbiology ,business.industry ,COVID-19 ,General Medicine ,Human decontamination ,biochemical phenomena, metabolism, and nutrition ,Contamination ,Computer keyboard ,Pulp and paper industry ,Dry fogging ,Infectious Diseases ,chemistry ,Fumigation ,Environmental science ,Health Facilities ,0305 other medical science ,business ,Disinfectants - Abstract
BackgroundThe SARS-Cov-2 pandemic has highlighted the urgent need for safe and effective surface decontamination methods, particularly in healthcare settings.MethodsThe effectiveness of peracetic acid (PAA) dry fogging in decontaminating common healthcare setting surfaces was evaluated after experimentally contaminating nine surfaces (stainless steel, latex painted wood, unsealed hardwood, melamine countertop, vinyl flooring, clear plastic, faux leather, computer keyboard button and smartphone touch screen) with more than 106 TCID50 of SARS-CoV-2.ResultsWhen fumigated with PAA dry fog for an hour, no infectious SARS-CoV-2 virus was recovered from experimentally inoculated coupons of representing nine different surface types. In contrast, high titer recovery of infectious virus was demonstrated for corresponding untreated drying controls of the same materials.ConclusionStandard surface decontaminating processes, including sprays and wipes, are laborious and often cannot completely decontaminate sensitive electronic equipment. The ease of use, low cost and overall effectiveness of a PAA dry fogging suggest it should be considered for decontaminating settings, particularly intensive care units where severely ill SARS-CoV-2 patients are cared for.
- Published
- 2020
17. Simulated sunlight decreases the viability of SARS-CoV-2
- Author
-
Jonathan Audet, Bryan D. Griffin, Samantha B Kasloff, Todd Cutts, Zachary Schiffman, Mable Chan, Angela Sloan, Darwyn Kobasa, Anders Leung, Guillaume Poliquin, and Derek R. Stein
- Subjects
Sunlight ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Environmental science ,skin and connective tissue diseases ,Virology - Abstract
The novel coronavirus, SARS-CoV-2, has spread into a pandemic since its emergence in Wuhan, China in December of 2019. This has been facilitated by its high transmissibility within the human population and its ability to remain viable on inanimate surfaces for an extended period. To address the latter, we examined the ability of sunlight to degrade SARS-CoV-2 on stainless steel. All assays were performed using a solar simulator at the equivalent of one air mass (i.e. equatorial sun at its Zenith). Heat-controlled experiments were conducted at approximately 34% relative humidity (RH); otherwise, RH decreased with sunlight exposure until a constant temperature was maintained. When initially suspended in tissue culture medium, the virus was rendered non-viable after two hours of sunlight exposure. However, when suspended in an organic matrix designed to mimic bodily secretions, three hours of continuous sunlight was required for complete degradation. From this work, we demonstrate that sunlight represents an effective decontamination method but the speed of decontamination is variable based on the underlying matrix. This information has an important impact on the development of infection prevention and control protocols to reduce the spread of this deadly pathogen.
- Published
- 2020
18. Stability of SARS-CoV-2 on Critical Personal Protective Equipment
- Author
-
James E. Strong, Todd Cutts, Samantha B Kasloff, and Duane J. Funk
- Subjects
Toxicology ,business.product_category ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Tyvek ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Healthcare settings ,Medicine ,Limiting ,Respirator ,business ,Personal protective equipment - Abstract
The spread of COVID-19 in healthcare settings is concerning, with healthcare workers representing a disproportionately high percentage of confirmed cases. Although SARS-CoV-2 virus has been found to persist on surfaces for a number of days, the extent and duration of fomites as a mode of transmission, particularly in healthcare settings, has not been fully characterized. To shed light on this critical matter, the present study provides the first comprehensive assessment of SARS-CoV-2 stability on experimentally contaminated personal protective equipment (PPE) widely used by healthcare workers and the general public. Persistence of viable virus was monitored over 21 days on eight different materials, including nitrile medical examination gloves, reinforced chemical resistant gloves, N-95 and N-100 particulate respirator masks, Tyvek®, plastic, cotton, and stainless steel. Unlike previous reports, viable SARS-CoV-2 in the presence of a soil load persisted for up to 21 days on experimentally inoculated PPE, including materials from filtering facepiece respirators (N-95 and N-100 masks) and a plastic visor. Conversely, when applied to 100% cotton fabric, the virus underwent rapid degradation and became undetectable in less than 24 hours. These findings underline the importance of appropriate handling of contaminated PPE during and following use in high-risk settings and provide interesting insight into the potential utility of cotton, including cotton masks, in limiting COVID-19 transmission.
- Published
- 2020
- Full Text
- View/download PDF
19. N95 Mask Decontamination using Standard Hospital Sterilization Technologies
- Author
-
Jay Krishnan, Samantha B Kasloff, Ryan Zarychanski, Kevin Hills, James E. Strong, Gloria Vazquez-Grande, Anders Leung, Todd Cutts, Sylvain A. Lother, Barret Rush, and Anand Kumar
- Subjects
business.product_category ,Fogging ,Waste management ,Human decontamination ,Sterilization (microbiology) ,Autoclave ,chemistry.chemical_compound ,chemistry ,Peracetic acid ,Environmental science ,Respirator ,business ,Hydrogen peroxide ,Personal protective equipment - Abstract
The response to the COVID-19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted, with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 5 different decontamination methods: autoclave treatment, ethylene oxide gassing, low temperature hydrogen peroxide gas plasma treatment, vaporous hydrogen peroxide exposure and peracetic acid dry fogging to decontaminate a variety of different N95 masks of experimental contamination with SARS-CoV-2 or Vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. We found that one cycle of treatment with all modalities was effective in decontamination and was associated with no structural or functional deterioration. Vaporous hydrogen peroxide, peracetic acid dry fogging and autoclave treatments were associated with no loss of structural or functional integrity to a minimum of 10 cycles for the mask models tested. The molded N95 masks however tolerated only 1 cycle of autoclaving. The successful application of autoclaving for layered fabric, pleated masks may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings.
- Published
- 2020
20. Simulated sunlight decreases the viability of SARS-CoV-2 in mucus
- Author
-
Bryan D. Griffin, Darwyn Kobasa, Angela Sloan, Todd Cutts, Anders Leung, Derek R. Stein, Jonathan Audet, Guillaume Poliquin, Mable Chan, Samantha B Kasloff, David Safronetz, and Zachary Schiffman
- Subjects
RNA viruses ,Light ,Coronaviruses ,Physiology ,medicine.disease_cause ,Mathematical and Statistical Techniques ,Pathogen ,Pathology and laboratory medicine ,Decontamination ,Virus Testing ,Coronavirus ,education.field_of_study ,Multidisciplinary ,Microbial Viability ,Physics ,Electromagnetic Radiation ,Statistics ,Medical microbiology ,Body Fluids ,Viruses ,Physical Sciences ,Sunlight ,Regression Analysis ,Medicine ,Solar Radiation ,SARS CoV 2 ,Pathogens ,Anatomy ,Research Article ,Ultraviolet radiation ,2019-20 coronavirus outbreak ,SARS coronavirus ,Science ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Population ,Linear Regression Analysis ,Biology ,Research and Analysis Methods ,Microbiology ,Diagnostic Medicine ,medicine ,Humans ,Statistical Methods ,Saliva ,education ,Medicine and health sciences ,Biology and life sciences ,SARS-CoV-2 ,Organisms ,Viral pathogens ,COVID-19 ,Mucus ,Microbial pathogens ,Virus Inactivation ,Ultraviolet B ,Mathematics - Abstract
The novel coronavirus, SARS-CoV-2, has spread into a pandemic since its emergence in Wuhan, China in December of 2019. This has been facilitated by its high transmissibility within the human population and its ability to remain viable on inanimate surfaces for an extended period. To address the latter, we examined the effect of simulated sunlight on the viability of SARS-CoV-2 spiked into tissue culture medium or mucus. The study revealed that inactivation took 37 minutes in medium and 107 minutes in mucus. These times-to-inactivation were unexpected since they are longer than have been observed in other studies. From this work, we demonstrate that sunlight represents an effective decontamination method but the speed of decontamination is variable based on the underlying matrix. This information has an important impact on the development of infection prevention and control protocols to reduce the spread of this deadly pathogen.
- Published
- 2021
21. Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model
- Author
-
Michael Gray, Shane Jones, Niaz Rahim, Samantha B Kasloff, Alexander Bello, Ray Saurette, Jarrid McKitrick, Charlene Ranadheera, Heinz Feldmann, Lauren Garnett, Kevin Tierney, Todd Cutts, Amrinder Dhaliwal, Steven Theriault, Darwyn Kobasa, Angela Sloan, Jason Gren, Nikesh Tailor, Cory Nakamura, Lauren Rondeau, James Kenny, Robert Vendramelli, Guodong Liu, Brad S. Pickering, Xiangguo Qiu, D Safronetz, Robert A. Kozak, B.J. Hancock, Jocelyn Edmonds, Mia J. Biondi, Yvon Deschambault, Reeni Soni, Sharron Hadder, Stephanie Kucas, James E. Strong, Liam Menec, Bradley W. M. Cook, Kaylie Tran, George Risi, Geoff Soule, Christy Press, Sam Aminian, Logan Banadyga, Gary P. Kobinger, Darryl Falzarano, Gary Wong, Sean Higgins, Daryl Schantz, Christine DeGraff, Bryan D. Griffin, Hugues Fausther Bovendo, Shihua He, Duane J. Funk, Anand Kumar, Anders Leung, Mable Hagan, Mark F. Allan, Trina Racine, Todd Mortimer, Murray Kesselman, Allen Grolla, Gregory Hansen, Alixandra Albietz, Bryce M. Warner, Derek R. Stein, Guillaume Poliquin, and University of Manitoba
- Subjects
medicine.medical_specialty ,Vasoactives ,Hydrocortisone ,MEDLINE ,NHP ,Disease ,Critical Care and Intensive Care Medicine ,medicine.disease_cause ,Pathophysiology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,medicine ,030212 general & internal medicine ,Intensive care medicine ,030304 developmental biology ,0303 health sciences ,Ebola virus ,Non human primate ,business.industry ,Research ,Published Erratum ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,Correction ,lcsh:RC86-88.9 ,Intensive care unit ,3. Good health ,Ventilatory support ,Ebola ,Fluid ,business ,Supportive care - Abstract
BackgroundThere are currently limited data for the use of specific antiviral therapies for the treatment of Ebola virus disease (EVD). While there is anecdotal evidence that supportive care may be effective, there is a paucity of direct experimental data to demonstrate a role for supportive care in EVD. We studied the impact of ICU-level supportive care interventions including fluid resuscitation, vasoactive medications, blood transfusion, hydrocortisone, and ventilator support on the pathophysiology of EVD in rhesus macaques infected with a universally lethal dose of Ebola virus strain Makona C07.MethodsFour NHPs were infected with a universally lethal dose Ebola virus strain Makona, in accordance with the gold standard lethal Ebola NHP challenge model. Following infection, the following therapeutic interventions were employed: continuous bedside supportive care, ventilator support, judicious fluid resuscitation, vasoactive medications, blood transfusion, and hydrocortisone as needed to treat cardiovascular compromise. A range of physiological parameters were continuously monitored to gage any response to the interventions.ResultsAll four NHPs developed EVD and demonstrated a similar clinical course. All animals reached a terminal endpoint, which occurred at an average time of 166.5 ± 14.8 h post-infection. Fluid administration may have temporarily blunted a rise in lactate, but the effect was short lived. Vasoactive medications resulted in short-lived improvements in mean arterial pressure. Blood transfusion and hydrocortisone did not appear to have a significant positive impact on the course of the disease.ConclusionsThe model employed for this study is reflective of an intramuscular infection in humans (e.g., needle stick) and is highly lethal to NHPs. Using this model, we found that the animals developed progressive severe organ dysfunction and profound shock preceding death. While the overall impact of supportive care on the observed pathophysiology was limited, we did observe some time-dependent positive responses. Since this model is highly lethal, it does not reflect the full spectrum of human EVD. Our findings support the need for continued development of animal models that replicate the spectrum of human disease as well as ongoing development of anti-Ebola therapies to complement supportive care.
- Published
- 2019
22. Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment
- Author
-
Logan Banadyga, Darryl Falzarano, Hugues Fausther Bovendo, Shihua He, Christine DeGraff, Todd Mortimer, Lauren Rondeau, Daryl Schantz, Guodong Liu, Mark F. Allan, Yvon Deschambault, Anders Leung, Sean Higgins, Steven Theriault, Murray Kesselman, Gary P. Kobinger, George Risi, Darwyn Kobasa, Sharron Hadder, Cory Nakamura, Duane J. Funk, Friederike Feldmann, Bradley W. M. Cook, Shane Jones, Reeni Soni, Gregory Hansen, Philippe Guillaume Poliquin, Ray Saurette, Alixandra Albietz, Heidi Wood, Bryce M. Warner, Todd Cutts, Anand Kumar, Mable Hagan, Samantha B Kasloff, Heinz Feldmann, Robert Vendramelli, Bryan D. Griffin, Stephanie Kucas, James E. Strong, Niaz Rahim, James Kenny, John Huynh, Charlene Ranadheera, Andrea Marzi, D Safronetz, Xiangguo Qiu, Kaylie Tran, Allen Grolla, Kevin Tierney, Michael Gray, Jocelyn Edmonds, Sam Aminian, Geoff Soule, Amrinder Dhaliwal, Nikesh Tailor, Derek R. Stein, Gary Wong, B.J. Hancock, Julie Kubay, Kimberly Azanarsky, Alexander Bello, Angela Sloan, Jason Gren, Lauren Garnett, Brad S. Pickering, Mia J. Biondi, Robert A. Kozak, Christy Press, Jarrid McKitrick, Trina Racine, and Liam Menec
- Subjects
0301 basic medicine ,Microbiology (medical) ,viral shedding ,medicine.medical_specialty ,environmental contamination ,viruses ,media_common.quotation_subject ,Disease ,medicine.disease_cause ,Microbiology ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Hygiene ,law ,Virology ,Intensive care ,Health care ,Medicine ,030212 general & internal medicine ,Viral shedding ,Intensive care medicine ,lcsh:QH301-705.5 ,media_common ,Ebola virus ,business.industry ,virus diseases ,Outbreak ,Intensive care unit ,3. Good health ,critical care ,030104 developmental biology ,lcsh:Biology (General) ,nosocomial infection ,Ebola ,business - Abstract
Background: The 2014–2016 Ebola outbreak in West Africa recapitulated that nosocomial spread of Ebola virus could occur and that health care workers were at particular risk including notable cases in Europe and North America. These instances highlighted the need for centers to better prepare for potential Ebola virus cases, including understanding how the virus spreads and which interventions pose the greatest risk. Methods: We created a fully equipped intensive care unit (ICU), within a Biosafety Level 4 (BSL4) laboratory, and infected multiple sedated non-human primates (NHPs) with Ebola virus. While providing bedside care, we sampled blood, urine, and gastric residuals, as well as buccal, ocular, nasal, rectal, and skin swabs, to assess the risks associated with routine care. We also assessed the physical environment at end-point. Results: Although viral RNA was detectable in blood as early as three days post-infection, it was not detectable in the urine, gastric fluid, or swabs until late-stage disease. While droplet spread and fomite contamination were present on a few of the surfaces that were routinely touched while providing care in the ICU for the infected animal, these may have been abrogated through good routine hygiene practices. Conclusions: Overall this study has helped further our understanding of which procedures may pose the highest risk to healthcare providers and provides temporal evidence of this over the clinical course of disease.
- Published
- 2021
23. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods
- Author
-
Barret Rush, Kevin Hills, Kimberly Malo, Gloria Vazquez-Grande, Paul Z. Chen, Samantha B Kasloff, Anders Leung, Sylvain A. Lother, James E. Strong, Jay Krishnan, Todd Cutts, Frank X. Gu, Ryan Zarychanski, and Anand Kumar
- Subjects
Ethylene Oxide ,RNA viruses ,business.product_category ,Plasma Gases ,Light ,Sanitization ,Coronaviruses ,02 engineering and technology ,Respirators ,Autoclave ,law.invention ,chemistry.chemical_compound ,Medical Conditions ,law ,Peracetic acid ,Medicine and Health Sciences ,Public and Occupational Health ,Respirator ,Decontamination ,Pathology and laboratory medicine ,Virus Testing ,0303 health sciences ,Multidisciplinary ,Physics ,Oxides ,Human decontamination ,Medical microbiology ,021001 nanoscience & nanotechnology ,Pulp and paper industry ,Peroxides ,Equipment Sterilization ,Physical sciences ,Chemistry ,Infectious Diseases ,Vesicular Stomatitis Virus ,Viruses ,Medicine ,Engineering and Technology ,SARS CoV 2 ,Pathogens ,0210 nano-technology ,Research Article ,Biotechnology ,Equipment Preparation ,Ultraviolet radiation ,Materials science ,Infectious Disease Control ,SARS coronavirus ,N95 Respirators ,Ultraviolet Rays ,Science ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Bioengineering ,Research and Analysis Methods ,Microbiology ,Rhabdoviruses ,03 medical and health sciences ,Electromagnetic radiation ,Diagnostic Medicine ,Equipment Reuse ,Humans ,Peracetic Acid ,Personal protective equipment ,Filtration ,Biology and life sciences ,SARS-CoV-2 ,030306 microbiology ,Organisms ,Viral pathogens ,Chemical Compounds ,COVID-19 ,Hydrogen Peroxide ,Vesiculovirus ,Microbial pathogens ,Health Care ,Autoclaving ,chemistry ,Medical Devices and Equipment ,Preventive Medicine ,Ultraviolet C ,business - Abstract
The response to the COVID-19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted, with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 7 different decontamination methods: autoclave treatment, ethylene oxide gassing (ETO), low temperature hydrogen peroxide gas plasma (LT-HPGP) treatment, vaporous hydrogen peroxide (VHP) exposure, peracetic acid dry fogging (PAF), ultraviolet C irradiation (UVCI) and moist heat (MH) treatment to decontaminate a variety of different N95 masks following experimental contamination with SARS-CoV-2 or vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. All methods except for UVCI were effective in total elimination of viable virus from treated masks. We found that all respirator masks tolerated at least one cycle of all treatment modalities without structural or functional deterioration as assessed by fit testing; filtration efficiency testing results were mostly similar except that a single cycle of LT-HPGP was associated with failures in 3 of 6 masks assessed. VHP, PAF, UVCI, and MH were associated with preserved mask integrity to a minimum of 10 cycles by both fit and filtration testing. A similar result was shown with ethylene oxide gassing to the maximum 3 cycles tested. Pleated, layered non-woven fabric N95 masks retained integrity in fit testing for at least 10 cycles of autoclaving but the molded N95 masks failed after 1 cycle; filtration testing however was intact to 5 cycles for all masks. The successful application of autoclaving for layered, pleated masks may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings. Given the ability to modify widely available heating cabinets on hospital wards in well-resourced settings, the application of moist heat may allow local processing of N95 masks.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.